{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:49:49Z","timestamp":1767804589733,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-025-03707-4","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T07:33:49Z","timestamp":1764833629000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome analysis unveils Th1 cell cycle signature as a distinctive feature of\u00a0mixed connective tissue disease"],"prefix":"10.1186","volume":"28","author":[{"given":"Yuichi","family":"Suwa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Nagafuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineto","family":"Ota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"2","key":"3707_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","volume":"52","author":"GC Sharp","year":"1972","unstructured":"Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease\u2013an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):148\u201359.","journal-title":"Am J Med"},{"issue":"1","key":"3707_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14397595.2019.1709944","volume":"31","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, Itoh Y, Yasuoka H, Fukaya S, Ashihara K, et al. 2019 diagnostic criteria for mixed connective tissue disease (MCTD): from the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol. 2021;31(1):29\u201333.","journal-title":"Mod Rheumatol"},{"issue":"3","key":"3707_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rdc.2005.04.011","volume":"31","author":"JE Pope","year":"2005","unstructured":"Pope JE. Other manifestations of mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31(3):519\u201333. vii.","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"3707_CR4","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1378\/chest.130.1.182","volume":"130","author":"O Sanchez","year":"2006","unstructured":"Sanchez O, Sitbon O, Ja\u00efs X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases-associated pulmonary arterial hypertension. Chest. 2006;130(1):182\u20139.","journal-title":"Chest"},{"key":"3707_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","volume":"48\u201349","author":"M Mosca","year":"2014","unstructured":"Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun. 2014;48\u201349:50\u20132.","journal-title":"J Autoimmun"},{"issue":"3","key":"3707_CR6","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/BF02229703","volume":"15","author":"PB Frandsen","year":"1996","unstructured":"Frandsen PB, Kriegbaum NJ, Ullman S, H\u00f8ier-Madsen M, Wiik A, Halberg P. Follow-up of 151 patients with high-titer U1RNP antibodies. Clin Rheumatol. 1996;15(3):254\u201360.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3707_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1136\/ard-2023-224537","volume":"83","author":"H Tanaka","year":"2024","unstructured":"Tanaka H, Okada Y, Nakayamada S, Miyazaki Y, Sonehara K, Namba S, Honda S, Shirai Y, Yamamoto K, Kubo S, et al. Extracting immunological and clinical heterogeneity across autoimmune rheumatic diseases by cohort-wide immunophenotyping. Ann Rheum Dis. 2024;83(2):242\u201352.","journal-title":"Ann Rheum Dis"},{"key":"3707_CR8","doi-asserted-by":"crossref","unstructured":"Izuka S, Komai T, Itamiya T, Ota M, Nagafuchi Y, Shoda H, Matsuki K, Yamamoto K, Okamura T, Fujio K. Machine learning-driven immunophenotypic stratification of mixed connective tissue disease corroborating the clinical heterogeneity. Rheumatology (Oxford) 2024.","DOI":"10.1093\/rheumatology\/keae158"},{"issue":"3","key":"3707_CR9","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1136\/ard.46.3.189","volume":"46","author":"E Genth","year":"1987","unstructured":"Genth E, Zarnowski H, Mierau R, Wohltmann D, Hartl PW. HLA-DR4 and Gm(1,3;5,21) are associated with U1-nRNP antibody positive connective tissue disease. Ann Rheum Dis. 1987;46(3):189\u201396.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3707_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/rheumatology\/kead341","volume":"63","author":"Y Todoroki","year":"2024","unstructured":"Todoroki Y, Satoh M, Kubo S, Kosaka S, Fukuyo S, Nakatsuka K, Saito K, Tanaka S, Nakayamada S, Tanaka Y. Anti-survival motor neuron complex antibodies as a novel biomarker for pulmonary arterial hypertension and interstitial lung disease in mixed connective tissue disease. Rheumatology (Oxford). 2024;63(4):1068\u201375.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"3707_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1002\/art.41610","volume":"73","author":"G Barturen","year":"2021","unstructured":"Barturen G, Babaei S, Catal\u00e0-Moll F, Mart\u00ednez-Bueno M, Makowska Z, Martorell-Marug\u00e1n J, Carmona-S\u00e1ez P, Toro-Dom\u00ednguez D, Carnero-Montoro E, Teruel M, et al. Integrative analysis reveals a molecular stratification of systemic autoimmune diseases. Arthritis Rheumatol. 2021;73(6):1073\u201385.","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"3707_CR12","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota M, Nagafuchi Y, Hatano H, Ishigaki K, Terao C, Takeshima Y, Yanaoka H, Kobayashi S, Okubo M, Shirai H, et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell. 2021;184(11):3006\u2013e30213017.","journal-title":"Cell"},{"issue":"5","key":"3707_CR13","doi-asserted-by":"publisher","first-page":"386","DOI":"10.2169\/internalmedicine.38.386","volume":"38","author":"R Kasukawa","year":"1999","unstructured":"Kasukawa R. Mixed connective tissue disease. Intern Med. 1999;38(5):386\u201393.","journal-title":"Intern Med"},{"issue":"9","key":"3707_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"3707_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology\/European league against rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"3707_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med. 1975;292(7):344\u20137.","journal-title":"N Engl J Med"},{"issue":"8","key":"3707_CR17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med. 1975;292(8):403\u20137.","journal-title":"N Engl J Med"},{"issue":"4","key":"3707_CR18","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1067\/mjd.2002.120621","volume":"46","author":"RD Sontheimer","year":"2002","unstructured":"Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sin\u00e9 myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol. 2002;46(4):626\u201336.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3707_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1002\/ana.410380504","volume":"38","author":"RC Griggs","year":"1995","unstructured":"Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, Rowland LP. Inclusion body myositis and myopathies. Ann Neurol. 1995;38(5):705\u201313.","journal-title":"Ann Neurol"},{"key":"3707_CR20","first-page":"5","volume":"17","author":"M Marcel","year":"2011","unstructured":"Marcel M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17:5\u20137.","journal-title":"EMBnet J"},{"issue":"1","key":"3707_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"issue":"2","key":"3707_CR22","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders S, Pyl PT, Huber W. HTSeq\u2013a python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"3707_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139\u201340.","journal-title":"Bioinformatics"},{"issue":"6","key":"3707_CR24","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The Sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133.","journal-title":"Bioinformatics"},{"issue":"1","key":"3707_CR25","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-016-1323-z","volume":"17","author":"GE Hoffman","year":"2016","unstructured":"Hoffman GE, Schadt EE. VariancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics. 2016;17(1):483.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"3707_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/C5MB00663E","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He QY. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12(2):477\u20139.","journal-title":"Mol Biosyst"},{"issue":"5","key":"3707_CR27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"2","key":"3707_CR28","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/bioinformatics\/btu640","volume":"31","author":"H Wu","year":"2015","unstructured":"Wu H, Wang C, Wu Z. PROPER: comprehensive power evaluation for differential expression using RNA-seq. Bioinformatics. 2015;31(2):233\u201341.","journal-title":"Bioinformatics"},{"key":"3707_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"key":"3707_CR30","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"issue":"18","key":"3707_CR31","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.cell.2022.07.021","volume":"185","author":"M Nakano","year":"2022","unstructured":"Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, Itamiya T, Maeda J, Yoshida R, Yamada S, et al. Distinct transcriptome architectures underlying lupus establishment and exacerbation. Cell. 2022;185(18):3375\u2013e33893321.","journal-title":"Cell"},{"issue":"6","key":"3707_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","volume":"81","author":"Y Takeshima","year":"2022","unstructured":"Takeshima Y, Iwasaki Y, Nakano M, Narushima Y, Ota M, Nagafuchi Y, Sumitomo S, Okamura T, Elkon K, Ishigaki K, et al. Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus. Ann Rheum Dis. 2022;81(6):845\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3707_CR33","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10238-020-00606-7","volume":"20","author":"MR Alves","year":"2020","unstructured":"Alves MR, Isenberg DA. Mixed connective tissue disease: a condition in search of an identity. Clin Exp Med. 2020;20(2):159\u201366.","journal-title":"Clin Exp Med"},{"issue":"7269","key":"3707_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature08512","volume":"462","author":"H Yanai","year":"2009","unstructured":"Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009;462(7269):99\u2013103.","journal-title":"Nature"},{"key":"3707_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.02.009","volume":"91","author":"MJ Lewis","year":"2018","unstructured":"Lewis MJ, McAndrew MB, Wheeler C, Workman N, Agashe P, Koopmann J, Uddin E, Morris DL, Zou L, Stark R, et al. Autoantibodies targeting TLR and SMAD pathways define new subgroups in systemic lupus erythematosus. J Autoimmun. 2018;91:1\u201312.","journal-title":"J Autoimmun"},{"issue":"7","key":"3707_CR36","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00296-018-4059-4","volume":"38","author":"A Dima","year":"2018","unstructured":"Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38(7):1169\u201378.","journal-title":"Rheumatol Int"},{"issue":"3","key":"3707_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5114\/reum.2015.53136","volume":"53","author":"A Paradowska-Gorycka","year":"2015","unstructured":"Paradowska-Gorycka A. U1-RNP and Toll-like receptors in the pathogenesis of mixed connective tissue diseasepart II. Endosomal TLRs and their biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia. 2015;53(3):143\u201351.","journal-title":"Reumatologia"},{"issue":"2","key":"3707_CR38","doi-asserted-by":"publisher","first-page":"105627","DOI":"10.1016\/j.jbspin.2023.105627","volume":"91","author":"A Mathian","year":"2024","unstructured":"Mathian A, Felten R, Alarcon-Riquelme ME, Psarras A, Mertz P, Chasset F, Vital EM, Arnaud L. Type 1 interferons: A target for immune-mediated inflammatory diseases (IMIDs). Joint Bone Spine. 2024;91(2):105627.","journal-title":"Joint Bone Spine"},{"issue":"4","key":"3707_CR39","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/path.1721","volume":"205","author":"J Wenzel","year":"2005","unstructured":"Wenzel J, W\u00f6renk\u00e4mper E, Freutel S, Henze S, Haller O, Bieber T, T\u00fcting T. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol. 2005;205(4):435\u201342.","journal-title":"J Pathol"},{"issue":"5","key":"3707_CR40","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1172\/JCI131700","volume":"130","author":"T Maehara","year":"2020","unstructured":"Maehara T, Kaneko N, Perugino CA, Mattoo H, Kers J, Allard-Chamard H, Mahajan VS, Liu H, Murphy SJ, Ghebremichael M, et al. Cytotoxic CD4\u2009+\u2009T lymphocytes May induce endothelial cell apoptosis in systemic sclerosis. J Clin Invest. 2020;130(5):2451\u201364.","journal-title":"J Clin Invest"},{"issue":"3","key":"3707_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s12016-021-08889-8","volume":"64","author":"ME Truchetet","year":"2023","unstructured":"Truchetet ME, Brembilla NC, Chizzolini C. Current concepts on the pathogenesis of systemic sclerosis. Clin Rev Allergy Immunol. 2023;64(3):262\u201383.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"3707_CR42","doi-asserted-by":"publisher","first-page":"eaaw8330","DOI":"10.1126\/sciadv.aaw8330","volume":"5","author":"Y Elyahu","year":"2019","unstructured":"Elyahu Y, Hekselman I, Eizenberg-Magar I, Berner O, Strominger I, Schiller M, Mittal K, Nemirovsky A, Eremenko E, Vital A, et al. Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv. 2019;5(8):eaaw8330.","journal-title":"Sci Adv"},{"issue":"93","key":"3707_CR43","doi-asserted-by":"publisher","first-page":"eadk1643","DOI":"10.1126\/sciimmunol.adk1643","volume":"9","author":"M Goto","year":"2024","unstructured":"Goto M, Takahashi H, Yoshida R, Itamiya T, Nakano M, Nagafuchi Y, Harada H, Shimizu T, Maeda M, Kubota A, et al. Age-associated CD4. Sci Immunol. 2024;9(93):eadk1643.","journal-title":"Sci Immunol"},{"key":"3707_CR44","doi-asserted-by":"crossref","unstructured":"van Leeuwen EM, Remmerswaal EB, Vossen MT, Rowshani AT, Wertheim-van Dillen PM, van Lier RA, ten, Berge IJ. Emergence of a CD4\u2009+\u2009CD28- granzyme B+, cytomegalovirus-specific T cell subset after recovery of primary cytomegalovirus infection. J Immunol 2004, 173(3):1834\u20131841.","DOI":"10.4049\/jimmunol.173.3.1834"},{"issue":"2","key":"3707_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/rheumatology\/kead207","volume":"63","author":"M Wildt","year":"2024","unstructured":"Wildt M, Andr\u00e9asson K, Hamberg V, Hesselstrand R, Wuttge DM. Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis. Rheumatology (Oxford). 2024;63(2):385\u201391.","journal-title":"Rheumatology (Oxford)"},{"key":"3707_CR46","doi-asserted-by":"crossref","unstructured":"Ohta R, Horinishi Y, Sano C, Ichinose K. Efficacy of mycophenolate mofetil in treating skin fibrosis in systemic sclerosis: A systematic review and Meta-Analysis. J Clin Med 2025; 14(12):4187.","DOI":"10.3390\/jcm14124187"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03707-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03707-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:05:34Z","timestamp":1767798334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-025-03707-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3707"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03707-4","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Ethics Committee of the University of Tokyo (approval number: G10095), and written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to Publish declaration: not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YN, MO and TO belonged to the Social Cooperation Program of the Department of Functional Genomics and Immunological Diseases, supported by Chugai Pharmaceutical.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}